AMR Clinical

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Osteoarthritis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• Alveus Therapeutics, Inc.1 trial
• Eli Lilly and Company1 trial

Running trials

• Recruiting

  Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  NCT07837973· Phase 2· Alveus Therapeutics, Inc.· Source

  Contact: Kate Aragundi

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Curtis Andrews (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Osteoarthritis1 recruiting